Crossmark

Ocrelizumab jetzt auch für die Stillzeit zugelassen

Crossref DOI link: https://doi.org/10.1007/s15005-025-4438-9

Published Online: 2025-08-18

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2025-08-01

Version of Record valid from 2025-08-01
More Information

Article History

First Online: 18 August 2025

Free to read: This content has been made available to all.